Centrum Medyczne HCP sp. z o.o

Poznan, Greater Poland Voivodeship 61-485

1 studies enrolling now · 4 studies all time

What they study most

Advanced Cholangiocarcinoma, Agitation Associated With Alzheimer's Disease Dementia, FGFR2 Gene Rearrangements, HER2-Positive Primary Breast Cancer, Migraine, Residual Invasive Breast Cancer

Studies at this site

• Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia — Recruiting now
• A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments — Completed
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early